Background. Probiotics prevent disease induced by Citrobacter rodentium, a murine-specific enteric pathogen. Whether probiotics can be used to interrupt the infectious process following initiation of ...

EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicated intra-abdominal infections, including those caused by ...

AbbVie's combination antibiotic Emblaveo has gotten federal approval to treat complicated intra-abdominal infections, making it the first and only such therapy approved to fight antimicrobial ...

The Food and Drug Administration (FDA) has approved Emblaveo™ (aztreonam and avibactam), in combination with metronidazole, for patients 18 years and older who have limited or no alternative options ...

In a recently published study, researchers based at Université Paris-Saclay identified OXA-1186, a novel carbapenemase related to the previously known OXA-198 enzyme, in a clinical isolate of ...

GSK said the U.S. Food and Drug Administration approved its Blujepa oral antibiotic for the treatment of female adults and children with uncomplicated urinary tract infections. The pharmaceutical ...

A 55-year-old woman was found to have acute myelomonocytic leukemia in March, 1968. Partial remission was induced and maintained with hydroxyurea and prednisone. The latter was discontinued because of ...